China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Seladelpar in Chinese Patients with Primary Biliary Cholangitis: A Real-World Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131274
Registration Time: 2026/08/31
Type: Observational study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Hainan Branch (Hainan Boao Research Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338976
Published by HT Digital Content Services with permission from Health Daily Digest....